ANGPTL3 impacts proteinuria and hyperlipidemia in primary nephrotic syndrome
Abstract Background It is unclear why primary nephrotic syndrome (PNS) patients often have dyslipidemia. Recent studies have shown that angiopoietin-like protein 3 (ANGPTL3) is an important regulator of lipid metabolism. In this study, we explored how ANGPTL3 impacts dyslipidemia during PNS developm...
Main Authors: | Fu Zhong, Shurao Liu, Yue Li, Guanyu Li, Ming Liu, Jingzhi Wang, Weijing Cui, Yanhong Suo, Xia Gao |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-04-01
|
Series: | Lipids in Health and Disease |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12944-022-01632-y |
Similar Items
-
Consequences of Nephrotic Proteinuria and Nephrotic Syndrome after Kidney Transplant
by: María José Ortega, et al.
Published: (2024-03-01) -
Comparison between outcomes of IgA nephropathy with nephrotic-range proteinuria and nephrotic syndrome: do podocytes play a role?
by: Yizhen Chen, et al.
Published: (2022-12-01) -
Tuberculosis infection in children with proteinuria/nephrotic syndrome
by: Hanna Szymanik-Grzelak, et al.
Published: (2017-10-01) -
ANGPTL3 is involved in kidney injury in high-fat diet-fed mice by suppressing ACTN4 expression
by: Guanyu Li, et al.
Published: (2022-09-01) -
Assessing the Accuracy of Diagnostic Tests to Quantify Proteinuria in Nephrotic Children: A Cross-Sectional Study
by: Hina Fatima Yahya, et al.
Published: (2023-10-01)